OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence.
about
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationImmune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaCD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells.Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosisSignaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor.The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory ResponsesAssociation of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.OX40, OX40L and Autoimmunity: a Comprehensive Review.Immunotherapy for advanced melanoma: future directions.Immune checkpoint therapy for non-small-cell lung cancer: an update.Therapeutic targeting of CD70 and CD27.Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities.Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma.PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell-Driven Antitumor Immunity.Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens.A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy
P2860
Q28068378-320B246E-10C8-48F1-8C0C-9FB6623A487AQ28069864-66F6658F-6E74-4C2F-B3E9-B2B78EA3287AQ35861968-1514CD34-D5F0-4AB8-B95F-1358422F4042Q35945226-FF6DD48B-7C77-4BF8-9264-76A3FB62257CQ36522770-152E10AB-08E2-4704-9CB4-41F51299318DQ36711034-7A458E19-93B0-4F62-A569-59A47D8096C4Q36940326-CD8DFBD0-5847-4B47-834F-AB11EAAF5945Q37474092-1B89829A-C99A-4DFF-8C26-D61B56F9E272Q38555213-4B948FBB-D883-4BA9-A0CE-3BF169388D1FQ38711163-2975E62F-D015-42EC-9FDE-1FAA164D8577Q38727542-5E9CCC2F-D35F-433A-B056-D35DEDD32126Q38749841-70B82C5C-7CB1-4A6E-A594-5CAFDF15483CQ38770814-195E8D03-B875-4133-989D-4D908AA194F6Q39111861-A2B8BF80-8589-4E1B-84E4-5CB704B91003Q47120629-AB1FF40E-998D-4D0B-A966-911CF3AC068CQ47325431-BAC0BFD5-B066-4673-AEF3-326B728A6160Q50266733-FF85790D-7291-47C3-8C82-B248276CA5FCQ52668712-582E0765-E725-4050-97CF-AEB04FC5B65DQ55262681-D87338F4-6B7D-4DFD-836C-5012330E4B33Q57038254-91C83E26-BCC4-43F3-BF49-C4787796B83A
P2860
OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@ast
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@en
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@nl
type
label
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@ast
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@en
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@nl
prefLabel
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@ast
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@en
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@nl
P2093
P2860
P50
P356
P1476
OX40- and CD27-mediated costim ...... 8+ T cells to exit quiescence.
@en
P2093
Anne Rogel
Aymen Al-Shamkhani
Barry Flutter
Ben Carpenter
Gordon J Freeman
Megan Sykes
Michael Croft
Noha Edwards
Sara Ghorashian
P2860
P304
P356
10.4049/JIMMUNOL.1401644
P407
P577
2014-11-17T00:00:00Z